Petrus Trust Company’s Pfizer PFE Stock Holding History

Petrus Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,038	Closed	-$362K	–	722
2024 Q1	$362K	Buy	+13,038	New	+$362K	0.03%	355
2023 Q3	–	Sell	-7,255	Closed	-$266K	–	696
2023 Q2	$266K	Buy	+7,255	New	+$282K	0.03%	430
2020 Q3	–	Sell	-7,605	Closed	-$236K	–	344
2020 Q2	$236K	Buy	+7,605	New	+$258K	0.03%	132
2020 Q1	–	Sell	-7,719	Closed	-$287K	–	291
2019 Q4	$287K	Hold	7,719	–	–	0.05%	139
2019 Q3	$263K	Buy	7,719 +1,961	+34%	+$71.3K	0.05%	130
2019 Q2	$237K	Hold	5,758	–	–	0.04%	172
2019 Q1	$232K	Buy	+5,758	New	+$231K	0.04%	188
2018 Q4	–	Sell	-7,857	Closed	-$328K	–	287
2018 Q3	$328K	Sell	7,857 -1,231	-14%	-$47.4K	0.07%	89
2018 Q2	$313K	Buy	9,088 +2,066	+29%	+$70.6K	0.07%	114
2018 Q1	$236K	Buy	+7,022	New	+$241K	0.05%	116

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Petrus Trust Company's PFE Position: Q2 2024 in Review

Petrus Trust Company sold out of Pfizer (PFE) in Q2 2024, closing a stake of 13,038 shares — an estimated $362K sold.

Petrus Trust Company first reported a position in PFE in Q1 2018 and held it in 10 quarters. The position peaked at $362K in Q1 2024. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Petrus Trust Company reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Petrus Trust Company sold 13,038 Pfizer shares in Q2 2024, an estimated $362K.
Petrus Trust Company first reported a position in Pfizer in Q1 2018 and held it in 10 quarters.
Petrus Trust Company's Pfizer position peaked at $362K in Q1 2024.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Petrus Trust Company's 13F filing for Q2 2024, filed 14 Aug 2024.